The Food and Drug Administration (FDA) submitted a report to Congress on the state of the CBD marketplace on Wednesday, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years. The report, which is responsive to a mandate attached … Continue reading FDA Updates Congress On CBD Product Labelling Accuracy